Price T Rowe Associates Inc Adc Therapeutics Sa Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Price T Rowe Associates Inc holds 28,831 shares of ADCT stock, worth $57,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,831
Previous 22,476 28.27%
Holding current value
$57,085
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.59 - $4.01 $16,459 - $25,483
6,355 Added 28.27%
28,831 $91,000
Q2 2024

Aug 14, 2024
BUY
$2.55 - $5.09 $57,313 - $114,402
22,476 New
22,476 $0
Q2 2023

Aug 14, 2023
SELL
$1.9 - $2.66 $160,740 - $225,036
-84,600 Reduced 6.48%
1,221,838 $2.63 Million
Q1 2023

May 15, 2023
SELL
$1.92 - $5.45 $347,264 - $985,725
-180,867 Reduced 12.16%
1,306,438 $2.55 Million
Q4 2022

Feb 14, 2023
BUY
$2.87 - $5.24 $851,101 - $1.55 Million
296,551 Added 24.9%
1,487,305 $5.71 Million
Q3 2022

Nov 14, 2022
SELL
$4.66 - $10.31 $3.59 Million - $7.94 Million
-770,456 Reduced 39.28%
1,190,754 $5.74 Million
Q2 2022

Aug 15, 2022
SELL
$5.96 - $14.99 $2.99 Million - $7.52 Million
-501,426 Reduced 20.36%
1,961,210 $15.6 Million
Q1 2022

May 16, 2022
SELL
$13.28 - $20.03 $5.16 Million - $7.79 Million
-388,801 Reduced 13.64%
2,462,636 $36.2 Million
Q4 2021

Feb 14, 2022
BUY
$19.29 - $31.51 $437,825 - $715,182
22,697 Added 0.8%
2,851,437 $57.6 Million
Q3 2021

Nov 15, 2021
BUY
$20.45 - $30.0 $3.4 Million - $4.98 Million
166,155 Added 6.24%
2,828,740 $76.8 Million
Q2 2021

Aug 16, 2021
SELL
$20.38 - $27.04 $1.7 Million - $2.25 Million
-83,209 Reduced 3.03%
2,662,585 $64.8 Million
Q1 2021

May 17, 2021
BUY
$22.75 - $34.05 $17.7 Million - $26.6 Million
780,033 Added 39.68%
2,745,794 $67 Million
Q4 2020

Feb 16, 2021
BUY
$25.26 - $38.02 $49.7 Million - $74.7 Million
1,965,761 New
1,965,761 $62.9 Million

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $154M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email